Clinical Performance of All-on-4 PEEK and Conventional Prostheses
Launched by UNIVERSITY OF SHARJAH · Apr 24, 2024
Trial Information
Current as of August 28, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The objectives of this randomized clinical trial are to 1) compare clinical performance of the two different treatment concepts during the follow up period of up to 3 years concerning prosthesis survival and success, 2) to assess the implants survival and success rates after 3 years, 3) to assess the accuracy of two surgical guides for full-arch implant surgery, 4) to assess the anticipated and actual pain following implant surgery, and 5) to assess patient satisfaction and quality of life will be assessed.
The study will be conducted according to the guidelines of the CONSORT statement fo...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • no contraindications for implant surgery (including uncontrolled systemic diseases)
- • sufficient bone height in the inter-foraminal area for an implant length of at least 10 mm
- • ridge width of 5.5 mm for implant insertion of at least 3.5 mm in diameter,
- Exclusion Criteria:
- • individuals who disagreed with being randomly allocated to the treatment study groups, those with signs of untreated temporomandibular disorders or uncontrolled systemic or oral conditions requiring additional treatment, participants unable to understand and answer the questionnaires used in the study, and unable to attend the scheduled post-treatment appointments for longitudinal data collection.
About University Of Sharjah
The University of Sharjah, a leading academic institution in the United Arab Emirates, is dedicated to advancing healthcare through innovative research and education. With a robust commitment to clinical excellence, the university actively sponsors clinical trials that aim to address pressing health challenges and improve patient outcomes. Leveraging state-of-the-art facilities and a multidisciplinary team of experts, the University of Sharjah fosters a collaborative environment that enhances the quality and impact of its research initiatives, ultimately contributing to the advancement of medical science and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sharjah, , United Arab Emirates
Patients applied
Trial Officials
Ahmed Aziz, PhD
Principal Investigator
University of Sharjah
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported